Intelligence Market Research

The global medical beds market is expected to reach US$ 5,710.7 Mn in 2027 from US$ 3,431.2 in 2017. The market is estimated to grow with a CAGR of 5.4% from 2019-2027. The growth of the medical beds market is primarily attributed to the factors such as rising geriatric population, increasing prevalence of chronic diseases, increasing number of hospitals, increased government investments and technological advancements in medical devices are major factors driving the growth of medical beds market. However, high cost associated with specialty beds such as bariatric, and critical care beds and clinical improvements in healthcare. On the other hand, growth opportunities in emerging regions is likely to have a positive impact on the growth of the global medical beds market in the coming years. With a rise in cases of chronic illnesses such as cancer, diabetes, cardiovascular diseases and hypertension, there has been a rise number of hospital admissions. Also, in recent days, there ha...

The global pacemakers market is expected to reach US$ 10,908.0 Mn in 2027 from US$ 5,485.4 in 2018. The market is estimated to grow with a CAGR of 8.1% from 2019-2027. Driving factors such as, increasing burden of cardiovascular diseases, neurological disorders & hearing disorders, increasing technological advancements, and large pool of geriatric population. Additionally, the future trends such as product innovations is likely to increase the growth of the pacemakers market in the forecasted period Get Sample PDF Of Pacemakers Market @ https://www.intelligencemarketresearch.com/ReportEnquiry?ReportID=11201907011147&req_type=sample In developed and maturing markets, major pacemakers companies are seeking for market growth by developing novel products. Growing demand for high quality healthcare services and products poses a need for rapid product innovations. Hence, over the years, companies are developing new products in order to meet the rising healthcare needs. ...

The global transradial access market is expected to reach US$ 2,961.79 Mn in 2027 from US$ 1,574.97 Mn in 2018. The market is estimated to grow with a CAGR of 7.7% from 2019-2027.  The market for transradial access is expected to grow, owing to factors such as rising inclination for interventional procedures using radial artery access, increasing prevalence of obesity & lifestyle diseases and growing use of radial access devices in pediatric patients. However, the factors such as product recalls & failures and high costs of vascular access devices are likely to adversely impact the growth of the market in the forecast period. Transradial catheterization is an endovascular procedure or catheterization procedure done for the diagnosis and treatment of arterial disease. Transradial artery access for percutaneous coronary intervention is related to lower bleeding and vascular complications than transfemoral artery access, particularly in patients with acute coronary synd...

The North America diabetes care devices market is expected to reach US$ 15,300.0 Mn in 2027 from US$ 8,936.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027. The growth of the diabetes care devices market is primarily attributed to the growing geriatric population and rapid technological advancements in diabetes care devices. However, high cost of diabetes care devices and risks associated with the insulin delivery devices are likely to pose a negative impact on the market growth. On the other hand, development of cost efficient pen needles is likely to have a positive impact on the growth of the North America diabetes care devices market in the coming years.  Get Sample PDF Of   North America Diabetes Care Devices Market @ https://www.intelligencemarketresearch.com/ReportEnquiry?ReportID=11201907011145&req_type=sample The advancement in the field of the healthcare industry is driving to the players for more research and dev...

The Europe diabetes care devices market is expected to reach US$ 11,184.6 Mn in 2027 from US$ 6,853.3 Mn in 2018. The market is estimated to grow with a CAGR of 5.7% from 2019-2027. The growth of the diabetes care devices market is primarily attributed to the rising incidence of diabetes and rising adoption of insulin injection pens over traditional syringes & vials. However, availability of alternatives for drug delivery and reuse of pen needles are likely to pose a negative impact on the market growth. On the other hand, increasing launch of GLP-1 analogues is likely to have a positive impact on the growth of the Europe diabetes care devices market in the coming years. Glucagon like Peptide-1 also known as GLP-1 is a hormone produced in the gut that is released in response to the food consumed by an individual. The peptide reduces the appetite of an individual and helps to secrete insulin in the body among obese patients. In recent years, external injection of GLP-1 ha...

The Asia Pacific diabetes care devices market is expected to reach US$ 8,880.7 Mn in 2027 from US$ 5,011.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027. The growth of the diabetes care devices market is primarily attributed to the rapid technological advancements in diabetes care devices and increasing rate of obesity. However, high cost of diabetes care devices and increasing prevalence of type 2 diabetes are likely to pose a negative impact on the market growth. On the other hand, growing medical tourism in developing countries is likely to have a positive impact on the growth of the Asia Pacific diabetes care devices market in the coming years. The advancement in the field of the healthcare industry is driving to the players for more research and developments for the diabetes care devices for the administration purpose required during various medical conditions. The pen needles used in various injection pens have evolved gradually in terms of...

The global pre-filled saline syringes market is expected to reach US$ 744.4 Mn in 2027 from US$ 402.5 Mn in 2018. The market is estimated to grow with a CAGR of 7.2% from 2019-2027. The growth of the pre-filled saline syringes market is primarily attributed to the factors such as the increasing prevalence of chronic diseases, rise in influence of hospital-acquired infections, increasing medication errors, risk of cross-contamination, high demand for hospital disposables, and a growing number of multispecialty hospitals. However, factors such as frequent product recall of pre-filled saline syringes are likely to pose a negative impact on market growth. On the other hand, growth opportunities in emerging regions are likely to have a positive impact on the growth of the global pre-filled saline syringes market in the coming years. With a rise in cases of chronic illnesses such as cancer, cardiovascular diseases, and hypertension, there has been a rise in awareness regarding one’s h...

The Europe next generation sequencing market is expected to reach US$ 7,685.4 Mn in 2025 from US$ 1,633.4 Mn in 2017. The market is estimated to grow with a CAGR of 21.4% from 2018-2025. The growth of the next generation sequencing market is primarily attributed to the technological advancements in sequencing and an extensive use of genomics for medical applications. However, nonexistence of skilled professionals and high risks associated with genetic data. On the other hand, an extensive use of genomics for medical applications is likely to have a positive impact on the growth of the Europe next generation sequencing market in the coming years. The genomics is comprised of various technologies such next generation sequencing (NGS), genome editing, gene synthesis and more. These technologies have been utilized for achieving various discoveries for the betterment of the health conditions across the living organisms. The next generation sequencing is widely used in the field o...

The global extracellular matrix market is expected to reach US$ 47.46 Mn in 2027 from US$ 24.30 Mn in 2018. The extracellular matrix market is estimated to grow with a CAGR of 8.2% from 2019-2027. The market is driven by the factors such as, significantly increasing incidences of trauma and cardiovascular diseases, increasing vascular reconstruction procedures and increasing product launches are likely to drive the growth of the extracellular matrix market. However, challenges during the usage of decellularized extracellular matrix is major challenge for the growth of the extracellular matrix market. Get Sample PDF Of Extracellular Matrix Market   @ https://www.intelligencemarketresearch.com/ReportEnquiry?ReportID=11201907011140&req_type=sample The significantly rising incidences of the orthopedic trauma conditions and cardiovascular diseases among others are the leading factors for the market growth. As a part of the treatment extracellular matrix serve seve...